Shahbazi, Reza http://orcid.org/0000-0002-0816-0733
Sghia-Hughes, Gabriella
Reid, Jack L.
Kubek, Sara
Haworth, Kevin G.
Humbert, Olivier
Kiem, Hans-Peter
Adair, Jennifer E. http://orcid.org/0000-0003-4599-016X
Article History
Received: 21 November 2018
Accepted: 23 April 2019
First Online: 27 May 2019
Competing interests
: H.-P.K., O.H. and J.E.A. received licensing revenue from Rocket Pharmaceuticals for research unrelated to this manuscript. K.G.H. is employed by and holds equity in Nohla Therapeutics. The other authors declare no competing interests associated with this work. J.E.A. and R.S. are co-inventors on US patent WO2018226762A1 entitled ‘Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies.’.